CelLBxHealth plc

Research CelLBxHealth plc (CLBX) on Bullrun: market cap GBX 2.97B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCLBX
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyGBX
• Market capGBX 2.97B
• Financial periodFY2024
• RevenueGBP 2.86M
• Revenue growth30.9%
• Net income-GBP 14.23M
• Free cash flow-GBP 13.89M
• Gross margin62.2%

Valuation Snapshot

latest market cap is GBX 2.97B.

About CelLBxHealth plc

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 system captures and harvests circulating tumour cells from blood.

Frequently asked questions

What is CelLBxHealth plc's market cap?

CelLBxHealth plc's market capitalization is GBX 2.97B.

What does CelLBxHealth plc do?

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.